Wed, Jul 23, 2014, 8:57 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Genomic Health Inc. Message Board

  • terry_amln terry_amln Sep 4, 2012 11:43 AM Flag

    The Newbridge connection .follow the money

    Its Steve Burrill - )

    Dubai, UAE: 04 September, 2012 - NewBridge Pharmaceuticals, a specialty therapeutics company focused on pharmaceuticals, biologics, diagnostics and medical devices serving the AfMET markets (Africa, Middle East, Turkey and Caspian regions), today announced that it has entered into an exclusive agreement with Genomic Health, Inc. (NASDAQ: GHDX), a global health company that provides actionable genomic information to personalize genomic health decisions.
    Through this agreement, Genomic Health Inc. will provide NewBridge Pharmaceuticals with Oncotype DX® test that can help physicians use their patients' tumor biology to go beyond the traditional clinical and pathologic factors to establish a more appropriate treatment plan for an individual patient." As part of this agreement, NewBridge will offer the Oncotype DX® tests for treatment of patients with early-stage, estrogen-positive (ER+) invasive breast cancer, ductal carcinoma in situ of the breast (DCIS), as well as colon cancer patients at stage II and III.

    Sentiment: Strong Buy

 
GHDX
27.49-0.11(-0.40%)Jul 23 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.